EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial

David Michael Miller, Elizabeth I. Buchbinder, Isaac Brownell, Karam Khaddour, Nikhil I. Khushalani, Justine V. Cohen, Vishal Anil Patel, Michael K. Wong

Journal of Cutaneous Oncology · 2026

DOI: 10.59449/joco.2026.09.25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Oncology, 2026. Verfasst von David Michael Miller und 7 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Miller, D. M., Buchbinder, E. I., Brownell, I., Khaddour, K., Khushalani, N. I., Cohen, J. V., Patel, V. A., & Wong, M. K. (2026). Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial. Journal of Cutaneous Oncology. https://doi.org/10.59449/joco.2026.09.25

Vancouver

Miller DM, Buchbinder EI, Brownell I, Khaddour K, Khushalani NI, Cohen JV, et al. Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial. Journal of Cutaneous Oncology. 2026. doi:10.59449/joco.2026.09.25

BibTeX
@article{Miller2026,
  author = {Miller, David Michael and Buchbinder, Elizabeth I. and Brownell, Isaac and Khaddour, Karam and Khushalani, Nikhil I. and Cohen, Justine V. and Patel, Vishal Anil and Wong, Michael K.},
  title = {Neoadjuvant Intralesional Daromun in Resectable Melanoma: Interpreting the PIVOTAL Trial},
  journal = {Journal of Cutaneous Oncology},
  year = {2026},
  doi = {10.59449/joco.2026.09.25}
}
Kostenlos starten →